AUD14.72
0.67% day before yesterday
Australia, Sep 06, 08:10 am CET
ISIN
AU000000CUV3
Symbol
CUV
Sector
Industry

Clinuvel Pharmaceutical Dividend history 7 years & estimates 2025 to 2027

Powered by StocksGuide
Register now for free to see the dividend history & estimates. Activate Now

Dividend Analysis of the Clinuvel Pharmaceutical Stock

Current dividend yield 8.77 %
Dividendenrendite 5 Jahre 7.81 %
Dividend Yield 10Y 7.41 %
Payout 3Y 2.36 %

When does Clinuvel Pharmaceutical pay a dividend?

Year Dividend Ex-day &
Payday
Frequency
Fiscal Year Dividend per Share Ex-Day Payday Payment frequency
2024
AUD0.05
AUD0.05
Sep 05 2024
Sep 05 2024
Sep 20 2024
Sep 05 24
Sep 20 24
Sep 20 2024
-
-
2023
AUD0.05
AUD0.05
Sep 05 2023
Sep 05 2023
Sep 20 2023
Sep 05 23
Sep 20 23
Sep 20 2023
-
-
2022
AUD0.04
AUD0.04
Sep 06 2022
Sep 06 2022
Sep 21 2022
Sep 06 22
Sep 21 22
Sep 21 2022
-
-
2021
AUD0.025
AUD0.03
Sep 02 2021
Sep 02 2021
Sep 17 2021
Sep 02 21
Sep 17 21
Sep 17 2021
-
-
2020
AUD0.025
AUD0.03
Sep 03 2020
Sep 03 2020
Sep 18 2020
Sep 03 20
Sep 18 20
Sep 18 2020
-
-
2019
AUD0.025
AUD0.03
Sep 04 2019
Sep 04 2019
Sep 19 2019
Sep 04 19
Sep 19 19
Sep 19 2019
-
-
2018
AUD0.02
AUD0.02
Sep 21 2018
Sep 21 2018
Oct 08 2018
Sep 21 18
Oct 08 18
Oct 08 2018
-
-

How much dividend does Clinuvel Pharmaceutical pay?

Clinuvel Pharmaceutical most recently paid a dividend of AUD0.05. Clinuvel Pharmaceutical paid a Dividend of AUD0.05 Per Share in the financial year 2024. With a stock price of AUD14.72 at Sep 06 2024, the current dividend yield is 0.34% (calculation: AUD0.05 / AUD14.72 = 0.34%). No special dividend was paid.

Use the StocksGuide screener to find the stocks with the highest dividend yields. Here you will find, for example, the 100 largest dividend stocks in the world:

What is the Clinuvel Pharmaceutical Dividend Yield and payout ratio?

The average Clinuvel Pharmaceutical dividend yield over the last 5 years is 0.17% and the average over the last 10 years is 0.15%.

The payout ratio of Clinuvel Pharmaceutical in relation to the last financial year is 6.94%. The payout ratio smoothed over 3 years is 7.95%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).

Metric Clinuvel Pharmaceutical
Current dividend yield 0.34%
Dividend Yield 5Y 0.17%
Dividend Yield 10Y 0.15%
Payout 1Y 6.94%
Payout 3Y 7.95%

Is the Clinuvel Pharmaceutical dividend safe? Continuity & Dividend Growth

Is the Clinuvel Pharmaceutical dividend safe?

Clinuvel Pharmaceutical has been paying a dividend for 7 years and has not lowered the dividend for 7 years (dividend continuity). As a result, the dividend was not increased recently.

The Dividend Growth in relation to the previous financial year amounts to 0.00%. The average Clinuvel Pharmaceutical Dividend Growth over the last 5 years is 14.87%.

Metric Clinuvel Pharmaceutical
Increased 0 Years
Continuity 7 Years
Paid 7 Years
Growth 1Y 0.00%
Growth 5Y 14.87%

Continuity

Clinuvel Pharmaceutical has been paying a dividend for 7 years and has not lowered the dividend for 7 years (dividend continuity). As a result, the dividend was not increased recently.

Dividend Growth

The Dividend Growth in relation to the previous financial year amounts to 0.00%. The average Clinuvel Pharmaceutical Dividend Growth over the last 5 years is 14.87%.

With the Stock Screener, you can search for the best Dividend Aristocrats in indices such as the DAX or NASDAQ.

Clinuvel Pharmaceutical Stock Forecast 2024

On the stock exchange, the Clinuvel Pharmaceutical stock (ISIN: AU000000CUV3) is not traded as a top scorer in September 2024 according to the dividend strategy.

The stock price of Clinuvel Pharmaceutical -7.70% has fallen since the beginning of the year 2024. However, the return generated in the past says nothing about the future return. You can find the Clinuvel Pharmaceutical stock price in real time at the top of the page.

Clinuvel Pharmaceutical (symbol: CUV) is valued at a Price / Earnings Ratio (P/E ratio) of 20.69 and a price/sales ratio (P/S ratio) of 8.36 valued. Based on analyst estimates, the Clinuvel Pharmaceutical stock forecast 2024 of the current financial year corresponds to a valuation of 19.41 according to P/E ratio and 7.50 according to P/S.

Metric Clinuvel Pharmaceutical
Dividend Score ??/15
Performance 2024
7.70%
P/E TTM 20.69
P/S TTM 8.36
P/E forward 19.41
P/S forward 7.50

Clinuvel Pharmaceutical (symbol: CUV) is valued at a Price / Earnings Ratio (P/E ratio) of 20.69 and a price/sales ratio (P/S ratio) of 8.36 valued. Based on analyst estimates, the Clinuvel Pharmaceutical stock forecast 2024 of the current financial year corresponds to a valuation of 19.41 according to P/E ratio and 7.50 according to P/S.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today